Preclinical validation of AR42, a novel histone deacetylase inhibitor, as treatment for vestibular schwannomas
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Preclinical validation of AR42, a novel histone deacetylase inhibitor, as treatment for vestibular schwannomas
Authors
Keywords
-
Journal
LARYNGOSCOPE
Volume 122, Issue 1, Pages 174-189
Publisher
Wiley
Online
2011-11-23
DOI
10.1002/lary.22392
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- AR42, a novel histone deacetylase inhibitor, as a potential therapy for vestibular schwannomas and meningiomas
- (2011) M. L. Bush et al. NEURO-ONCOLOGY
- HDAC-mediated control of ERK- and PI3K-dependent TGF-β-induced extracellular matrix-regulating genes
- (2010) Matt J. Barter et al. MATRIX BIOLOGY
- ErbB/HER receptor activation and preclinical efficacy of lapatinib in vestibular schwannoma
- (2010) S. Ammoun et al. NEURO-ONCOLOGY
- p21 Downregulation is an important component of PAX3/FKHR oncogenicity and its reactivation by HDAC inhibitors enhances combination treatment
- (2010) R M Hecker et al. ONCOGENE
- Blockade of the ERK or PI3K–Akt signaling pathway enhances the cytotoxicity of histone deacetylase inhibitors in tumor cells resistant to gefitinib or imatinib
- (2009) Kei-ichi Ozaki et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Akt Phosphorylation of Merlin Enhances Its Binding to Phosphatidylinositols and Inhibits the Tumor-Suppressive Activities of Merlin
- (2009) M. Okada et al. CANCER RESEARCH
- Growth inhibitory and anti-tumour activities of OSU-03012, a novel PDK-1 inhibitor, on vestibular schwannoma and malignant schwannoma cells
- (2009) Tina X. Lee et al. EUROPEAN JOURNAL OF CANCER
- Activation of ERK, AKT and JNK signalling pathways in human schwannomasin situ
- (2009) David A Hilton et al. HISTOPATHOLOGY
- Neurofibromatosis type 2 (NF2): A clinical and molecular review
- (2009) D Gareth R Evans Orphanet Journal of Rare Diseases
- Phosphatidylinositol 3-Kinase/AKT Pathway Activation in Human Vestibular Schwannoma
- (2009) Abraham Jacob et al. OTOLOGY & NEUROTOLOGY
- Merlin and the ERM proteins – regulators of receptor distribution and signaling at the cell cortex
- (2009) Andrea I. McClatchey et al. TRENDS IN CELL BIOLOGY
- HDAC6 inhibition enhances 17-AAG-mediated abrogation of hsp90 chaperone function in human leukemia cells
- (2008) R. Rao et al. BLOOD
- Dissecting and Targeting the Growth Factor-Dependent and Growth Factor-Independent Extracellular Signal-Regulated Kinase Pathway in Human Schwannoma
- (2008) S. Ammoun et al. CANCER RESEARCH
- OSU-HDAC42, a Histone Deacetylase Inhibitor, Blocks Prostate Tumor Progression in the Transgenic Adenocarcinoma of the Mouse Prostate Model
- (2008) A. M. Sargeant et al. CANCER RESEARCH
- Heat Shock Protein 90 as a Drug Target: Some Like It Hot
- (2008) U. Banerji CLINICAL CANCER RESEARCH
- HDAC inhibition upregulates the expression of angiostatic ADAMTS1
- (2008) Chia-Wei Chou et al. FEBS LETTERS
- A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas
- (2008) S Balasubramanian et al. LEUKEMIA
- A natural histone deacetylase inhibitor, Psammaplin A, induces cell cycle arrest and apoptosis in human endometrial cancer cells
- (2007) Mee Young Ahn et al. GYNECOLOGIC ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now